HALOZYME THERAPEUTICS, INC.
RESTRICTED STOCK AGREEMENT
Halozyme Therapeutics, Inc. has granted to the Participant named in the Notice of Grant of Restricted
Stock (the “ Grant Notice ”) to which this Restricted Stock Agreement (the “ Agreement ”) is attached an
Award consisting of Shares subject to the terms and conditions set forth in the Grant Notice and this Agreement.
The Award has been granted pursuant to and shall in all respects be subject to the terms and conditions of the
Halozyme Therapeutics, Inc. 2008 Outside Directors’ Stock Plan (the “ Plan ”), as amended to the Date of
Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant:
(a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this
Agreement, the Plan and a prospectus for the Plan in the form most recently registered with the Securities and
Exchange Commission (the “ Plan Prospectus ”), (b) accepts the Award subject to all of the terms and
conditions of the Grant Notice, this Agreement and the Plan and (c) agrees to accept as binding, conclusive and
final all decisions or interpretations of the Board upon any questions arising under the Grant Notice, this
Agreement or the Plan.
1. DEFINITIONS AND CONSTRUCTION .
1.1 Definitions . Unless otherwise defined herein, capitalized terms shall have the meanings assigned
to such terms in the Grant Notice or the Plan.
1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the
meaning or interpretation of any provision of this Agreement. Except when otherwise indicated by the context, the
singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be
exclusive, unless the context clearly requires otherwise.
2. ADMINISTRATION .
All questions of interpretation concerning the Grant Notice and this